Overall, hxt0GLUT5 is a convenient, versatile, low-cost, GLUT5-specific, and fast system for identification and characterization of human GLUT5 ligands, allowing the screening of compound libraries for potential GLUT5 effectors that could serve as drugs for cancer, metabolic disease, and diabetes. Here, SLC2A5 is linked to cancer.